In Opposition proceedings brought by Teva regarding IL 130424 to Pfizer, the IP Arbitrator Read the rest of this entry »
Teva Scores Double Strike Against Merck’s Patent for Alendronate
February 25, 2008Teva, Israel’s leading drug company. has announced that courts in both the Netherlands and France separately invalidated Merck Sharp & Dohme’s (subsidiary of Merck & Co.) European patent for alendronate Read the rest of this entry »
Iraq Waives Israel Boycott Declaration Requirement
February 21, 2008It is apparently now possible to get trademark registrations in Iraq without declaring compliance with the Israel Boycott.
The End of Business Patents in the US?
February 18, 2008In Re Bilski USSN 08/833,892 relating to hedging risks, the Federal Circuit Court of Appeals (CAFC) has decided to review the whole concept of business Read the rest of this entry »
Could US Copyright Law be in for a Change?
February 16, 2008Copyright, like most controversial issues tends to have its swings and roundabouts. In the US, copyright Read the rest of this entry »
EU Considering Extending Performer’s Rights to 90 Years
February 15, 2008Following the US down the slippery slope to making copyright last for ever, the European Commission has proposed extending the performer’s rights from Read the rest of this entry »
First-to-Invent to First-to-File Conversion
February 12, 2008The US Small Business Alliance claims:
Despite the appeal of international harmonization, America’s unique patent Read the rest of this entry »
Posted by Dr Michael Factor 